- Home
- AMBI vs NKTR Comparison
AMBI vs NKTR Comparison
Compare AMBI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBI
- NKTR
- Stock Information
- Founded
- AMBI 1995
- NKTR 1990
- Country
- AMBI Brazil
- NKTR United States
- Employees
- AMBI N/A
- NKTR N/A
- Industry
- AMBI Environmental Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- AMBI Industrials
- NKTR Health Care
- Exchange
- AMBI Nasdaq
- NKTR Nasdaq
- Market Cap
- AMBI 278.5M
- NKTR 108.3M
- IPO Year
- AMBI N/A
- NKTR 1994
- Fundamental
- Price
- AMBI $4.72
- NKTR $24.48
- Analyst Decision
- AMBI
- NKTR Strong Buy
- Analyst Count
- AMBI 0
- NKTR 6
- Target Price
- AMBI N/A
- NKTR $77.50
- AVG Volume (30 Days)
- AMBI 13.2K
- NKTR 4.6M
- Earning Date
- AMBI 01-01-0001
- NKTR 08-07-2025
- Dividend Yield
- AMBI N/A
- NKTR N/A
- EPS Growth
- AMBI N/A
- NKTR N/A
- EPS
- AMBI N/A
- NKTR N/A
- Revenue
- AMBI $525,221,427.00
- NKTR $87,248,000.00
- Revenue This Year
- AMBI N/A
- NKTR N/A
- Revenue Next Year
- AMBI N/A
- NKTR N/A
- P/E Ratio
- AMBI N/A
- NKTR N/A
- Revenue Growth
- AMBI 25.42
- NKTR N/A
- 52 Week Low
- AMBI $3.22
- NKTR $6.48
- 52 Week High
- AMBI $8.20
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- AMBI 50.60
- NKTR 68.00
- Support Level
- AMBI $4.44
- NKTR $8.27
- Resistance Level
- AMBI $5.25
- NKTR $26.59
- Average True Range (ATR)
- AMBI 0.39
- NKTR 3.71
- MACD
- AMBI 0.00
- NKTR 1.18
- Stochastic Oscillator
- AMBI 43.43
- NKTR 57.06
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.